Armando Valdesowned and operated Gasiel Medical Services Corp., a medical clinic in Miami from February 2015 through July 2021, according to the Justice Department.
Dr. Valdes allegedly submitted about $38 million in fraudulent claims to United Healthcare and Blue Cross Blue Shield for infusions of the prescription drug Infliximab, prosecutors said.
A single dose of Infliximab can have a retail price of nearly $10,000, the Justice Department reported.
In his guilty plea earlier this year, Dr. Valdes stated that he never provided an infusion of Infliximab and that patients of the clinic did not require the medication, according to the Justice Department.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.